Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

This publication has 18 references indexed in Scilit:

• Coliform Contamination of Vegetables Obtained from Popular Restaurants in Guadalajara, Mexico, and Houston, Texas
  Clinical Infectious Diseases, 2008
• Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
  The Lancet, 2008
• Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch
  Vaccine, 2008
• Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum
  Infection and Immunity, 2007
• Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico
  Vaccine, 2007
• Oral cholera vaccines: use in clinical practice
  The Lancet Infectious Diseases, 2006
• Serologic Correlates of Protection against EnterotoxigenicEscherichia coliDiarrhea
  The Journal of Infectious Diseases, 2005
• Prevalence of Enteric Pathogens among International Travelers with Diarrhea Acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
  The Journal of Infectious Diseases, 2002
• Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine
  The Lancet, 1991
• A New Test for 2 × 2 Tables
  Nature, 1945